Summary/Conclusion
IOERT boost during surgery not only enables good local control without geometric miss of the tumor, but also delivers good cosmetic effect after therapy.
Read MoreSummary/Conclusion
IOERT boost during surgery not only enables good local control without geometric miss of the tumor, but also delivers good cosmetic effect after therapy.
Read MoreSummary/Conclusion
IOERT resulted in a reduction of treatment time, was not associated with additional toxicity or change in the acute toxicity profile, and is a feasible treatment option in a community setting.
Read MoreSummary/Conclusion
IOERT is a feasible technique and can be viewed as a tool in the treatment of newly diagnosed and recurrent brain gliomas.
Read MoreSummary/Conclusion
Both univariate and multivariate analysis revealed the survival rate was significantly higher in patients that received IORT than in those that did not (p = 0.026). There were no perioperative complications attributed to IORT. IORT for esophageal carcinoma will likely be effective for patients with a primary lesion in the lower thoracic or abdominal esophagus, or with a long lesion.
Read MoreCancer Indication
Number of Patients
226
Summary/Conclusion
APBI using a single dose of IOERT can be delivered safely in women with early, low-risk breast cancer in carefully selected patients.
Read More